3Z PHARMACEUTICALS
3Z Pharmaceuticals provides research services intended to provide drug development services. It offers drug screening on sleep and epilepsy assays that helps in the development of drugs used to treat neurological disorders, enabling patients to get multiple drug efficacy and toxicity assays. Karl Karlsson and Haraldur Thorsteinsson founded 3Z Pharmaceuticals in 2008. It based their company on their research on the sleeping patterns of the zebrafish at the Reykjavik University Neurolab in 2006.
3Z PHARMACEUTICALS
Industry:
Consulting Health Care Medical Pharmaceutical Product Research
Founded:
2008-01-01
Address:
Reykjavík, Gullbringusysla, Iceland
Country:
Iceland
Website Url:
http://www.3z.is
Total Employee:
1+
Status:
Active
Contact:
(354)599-6434
Email Addresses:
[email protected]
Total Funding:
3.71 M USD
Technology used in webpage:
SPF Euro Google Apps For Business Pound Sterling Japanese Yen 1984
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aprea
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Employees Featured
Founder
Investors List
New Business Venture Fund
New Business Venture Fund investment in Seed Round - 3Z Pharmaceuticals
Probiocon
Probiocon investment in Seed Round - 3Z Pharmaceuticals
Probiocon
Probiocon investment in Seed Round - 3Z Pharmaceuticals
Sigþór Sigmarsson
Sigþór Sigmarsson investment in Seed Round - 3Z Pharmaceuticals
Baliopharm
Baliopharm investment in Seed Round - 3Z Pharmaceuticals
New Business Venture Fund
New Business Venture Fund investment in Seed Round - 3Z Pharmaceuticals
Technology Development Fund
Technology Development Fund investment in Grant - 3Z Pharmaceuticals
Technology Development Fund
Technology Development Fund investment in Grant - 3Z Pharmaceuticals
Technology Development Fund
Technology Development Fund investment in Grant - 3Z Pharmaceuticals
Technology Development Fund
Technology Development Fund investment in Grant - 3Z Pharmaceuticals
Official Site Inspections
http://www.3z.is
- Host name: judy.shared.1984.is
- IP address: 185.112.145.135
- Location: Iceland
- Latitude: 65
- Longitude: -18
- Timezone: Atlantic/Reykjavik
More informations about "3Z Pharmaceuticals" on Search Engine
3Z Pharmaceuticals
Jun 20, 2022 3Z incorporates the latest advances in disease modeling and behavioral genetics to discover novel drug candidates for CNS disorders. DISCOVER. RESEARCH. Drug repurposing, also known as drug …See details»
3Z Pharmaceuticals - Crunchbase Company Profile & Funding
Health Care. Medical. Pharmaceutical. Product Research. Headquarters Regions Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) Founded Date Jan …See details»
3Z Pharmaceuticals | LinkedIn
3Z Pharmaceuticals | 693 followers on LinkedIn. Accelerated CNS drug discovery | 3Z uses advanced disease modeling and behavioral genetics to discover novel drug …See details»
Our team – 3Z Pharmaceuticals
Karl Æ. Karlsson, CEO & Co-founder. Professor and Head of Neurolab at the University of Reykjavik Biomedical Center. 20+ years experience with animal behavioral models. …See details»
Our method – 3Z Pharmaceuticals
OUR METHOD. 3Z has developed unique high throughput zebrafish screening assays based on behavioural analysis. NEW PURPOSE. Our specialization lies in finding new …See details»
Co-Founder, CEO & CSO @ 3Z Pharmaceuticals - Crunchbase
Overview. Number of Founded Organizations 1. CB Rank (Person) 625,499. Primary Job Title Co-Founder, CEO & CSO. Primary Organization. 3Z Pharmaceuticals. Location …See details»
3Z Pharmaceuticals - Funding, Financials, Valuation & Investors
Funding. 3Z Pharmaceuticals has raised a total of. $3.7M. in funding over 10 rounds. Their latest funding was raised on Jun 20, 2022 from a Seed round. 3Z Pharmaceuticals is …See details»
3Z Pharmaceuticals CEO and Key Executive Team | Craft.co
Home. / 3Z Pharmaceuticals. / Executives. 3Z Pharmaceuticals CEO and Key Executive Team. 3Z Pharmaceuticals's Co-Founder - CSO is Karl Karlsson. 3Z …See details»
3Z Pharmaceuticals Company Profile - Craft
3Z Pharmaceuticals is a contract research organization engaged in pharma development services. It specializes in assays, screening, and consulting services. Type. Private. …See details»
3Z Pharmaceuticals: Drug pipelines, Patents, Clinical trials
Explore 3Z Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Technology Platform:Small molecule drug, …See details»
3Z Pharmaceuticals - Raised $2.4M Funding from 3 investors
Apr 18, 2024 Drug screening technology for CNS disorders. Last updated: April 18, 2024. Summary of Funding Rounds of 3Z Pharmaceuticals. Funding Rounds. 4. 2 Seed / 1 …See details»
3Z Pharmaceuticals completed a $2M funding round | Nordic 9
Jun 17, 2022 Company: 3Z Pharmaceuticals. Industry: Health services Pharma. Related deals Prescriby raised €2 million in a seed round led by Crowberry Capital. Health …See details»
News – 3Z Pharmaceuticals
3Z closes $2 million funding for preclinical development of novel ADHD and Insomnia therapeutics identified by 3Z´s zebrafish drug discovery platform. Read More ». June 20, …See details»
3Z Pharmaceuticals - Contacts, Employees, Board Members
3Z Pharmaceuticals focuses on developing drugs that would improve the central nervous system.See details»
3Z-20-001(3Z Pharmaceuticals) - Drug Targets, Indications, …
Mar 20, 2024 3Z Pharmaceuticals. Active Organization. 3Z Pharmaceuticals. Inactive Organization - Drug Highest Phase Preclinical. First Approval Date - Regulation - …See details»
Pipeline – 3Z Pharmaceuticals
We focus on the development of repurposed small molecule drugs targeting neurological indications facilitated by our unique, behaviour based zebrafish screening technology. …See details»
3Z Pharmaceuticals - Updates, News, Events, Signals & Triggers …
3Z Pharmaceuticals focuses on developing drugs that would improve the central nervous system.See details»
3Z-20-002(3Z Pharmaceuticals) - Drug Targets, Indications, …
Apr 2, 2024 3Z-20-002(3Z Pharmaceuticals), Initially developed by 3Z Pharmaceuticals, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Other Diseases, …See details»
Zebrafish – 3Z Pharmaceuticals
ZEBRAFISH. IN VIVO SCREENING. 3Z has developed unique high throughput zebrafish in vivo screening assays based on behavioural analysis. NEUROLOGICAL. These assays …See details»
WHO clears Takeda's dengue vaccine | Reuters
1 day ago May 15 (Reuters) - The World Health Organization (WHO) said on Wednesday that it had cleared Takeda Pharmaceuticals' (4502.T) dengue vaccine, giving …See details»